Tanzania Deploys ‘HeroRats’ to Improve Tuberculosis Diagnosis 06/01/2023 Kizito Makoye For months, Sharifa Shomale suffered in silence from tuberculosis, not knowing what was wrong with her. Doctors suspected a viral infection. Then an unlikely hero made a life-saving discovery: a mischievous rat named Hamisi. DAR ES SALAAM, Tanzania—Every evening, as the call to prayer from the mosque echoes in the twilight from Manzese—a tangled Dar […] Continue reading -> US National Institutes of Health and Israel To Kick-off Joint Research Into Regional Emerging Disease Threats 05/01/2023 Maayan Hoffman In the wake of the COVID pandemic, the US National Institutes of Health (NIH) and Israel’s largest medical center, Sheba Medical Center, are launching a scientific collaboration aimed at identifying emerging disease threats in the region. One of the first projects planned will be a study examining the impacts on antibody defenses amongst travelers from […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Sweeping New Global Biodiversity Deal Sets Out Plan for Sharing Gene Sequences 20/12/2022 Stefan Anderson Along with a pledge to conserve 30% of the world’s biodiversity, the sweeping new deal reached in Montreal on Monday also etches a way forward to create an open-access platform for sharing gene sequences (digital sequence information) as part of new benefit-sharing arrangements. But some observers worry these policy advances still aren’t keeping up with […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> WHO Director General: Hopes COVID Global Health Emergency Can Be Declared Over in 2023 14/12/2022 Elaine Ruth Fletcher There are emerging hopes that sometime in 2023, WHO can declare that the COVID-19 global health emergency is over, said WHO Director General Dr Tedros Adhanom Ghebreyesus, speaking at a pre-holiday press briefing on Wednesday. Meanwhile, however, the world continues to invest some $2 trillion in wars and “killing each other” – but not nearly […] Continue reading -> Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US National Institutes of Health and Israel To Kick-off Joint Research Into Regional Emerging Disease Threats 05/01/2023 Maayan Hoffman In the wake of the COVID pandemic, the US National Institutes of Health (NIH) and Israel’s largest medical center, Sheba Medical Center, are launching a scientific collaboration aimed at identifying emerging disease threats in the region. One of the first projects planned will be a study examining the impacts on antibody defenses amongst travelers from […] Continue reading -> Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Sweeping New Global Biodiversity Deal Sets Out Plan for Sharing Gene Sequences 20/12/2022 Stefan Anderson Along with a pledge to conserve 30% of the world’s biodiversity, the sweeping new deal reached in Montreal on Monday also etches a way forward to create an open-access platform for sharing gene sequences (digital sequence information) as part of new benefit-sharing arrangements. But some observers worry these policy advances still aren’t keeping up with […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> WHO Director General: Hopes COVID Global Health Emergency Can Be Declared Over in 2023 14/12/2022 Elaine Ruth Fletcher There are emerging hopes that sometime in 2023, WHO can declare that the COVID-19 global health emergency is over, said WHO Director General Dr Tedros Adhanom Ghebreyesus, speaking at a pre-holiday press briefing on Wednesday. Meanwhile, however, the world continues to invest some $2 trillion in wars and “killing each other” – but not nearly […] Continue reading -> Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Vaccine Trial Against Sudan Ebolavirus – With No Recent Infections in Uganda, What’s Plan B? 23/12/2022 Elaine Ruth Fletcher The World Health Organization (WHO) isn’t talking about it publicly, but behind the scenes WHO is planning a meeting for 12 January to evaluate next steps, Health Policy Watch has learned, as the absence of new cases in the Uganda outbreak makes it impossible to begin a clinical trial based on a ring vaccination of […] Continue reading -> Sweeping New Global Biodiversity Deal Sets Out Plan for Sharing Gene Sequences 20/12/2022 Stefan Anderson Along with a pledge to conserve 30% of the world’s biodiversity, the sweeping new deal reached in Montreal on Monday also etches a way forward to create an open-access platform for sharing gene sequences (digital sequence information) as part of new benefit-sharing arrangements. But some observers worry these policy advances still aren’t keeping up with […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> WHO Director General: Hopes COVID Global Health Emergency Can Be Declared Over in 2023 14/12/2022 Elaine Ruth Fletcher There are emerging hopes that sometime in 2023, WHO can declare that the COVID-19 global health emergency is over, said WHO Director General Dr Tedros Adhanom Ghebreyesus, speaking at a pre-holiday press briefing on Wednesday. Meanwhile, however, the world continues to invest some $2 trillion in wars and “killing each other” – but not nearly […] Continue reading -> Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sweeping New Global Biodiversity Deal Sets Out Plan for Sharing Gene Sequences 20/12/2022 Stefan Anderson Along with a pledge to conserve 30% of the world’s biodiversity, the sweeping new deal reached in Montreal on Monday also etches a way forward to create an open-access platform for sharing gene sequences (digital sequence information) as part of new benefit-sharing arrangements. But some observers worry these policy advances still aren’t keeping up with […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> WHO Director General: Hopes COVID Global Health Emergency Can Be Declared Over in 2023 14/12/2022 Elaine Ruth Fletcher There are emerging hopes that sometime in 2023, WHO can declare that the COVID-19 global health emergency is over, said WHO Director General Dr Tedros Adhanom Ghebreyesus, speaking at a pre-holiday press briefing on Wednesday. Meanwhile, however, the world continues to invest some $2 trillion in wars and “killing each other” – but not nearly […] Continue reading -> Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> WHO Director General: Hopes COVID Global Health Emergency Can Be Declared Over in 2023 14/12/2022 Elaine Ruth Fletcher There are emerging hopes that sometime in 2023, WHO can declare that the COVID-19 global health emergency is over, said WHO Director General Dr Tedros Adhanom Ghebreyesus, speaking at a pre-holiday press briefing on Wednesday. Meanwhile, however, the world continues to invest some $2 trillion in wars and “killing each other” – but not nearly […] Continue reading -> Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> WHO Director General: Hopes COVID Global Health Emergency Can Be Declared Over in 2023 14/12/2022 Elaine Ruth Fletcher There are emerging hopes that sometime in 2023, WHO can declare that the COVID-19 global health emergency is over, said WHO Director General Dr Tedros Adhanom Ghebreyesus, speaking at a pre-holiday press briefing on Wednesday. Meanwhile, however, the world continues to invest some $2 trillion in wars and “killing each other” – but not nearly […] Continue reading -> Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Medicines for Malaria Venture Joins African Manufacturing Initiative 15/12/2022 Stefan Anderson The Medicines for Malaria Venture (MMV) and African Centers for Disease control signed a Memorandum of Understanding (MoU) on Thursday to providing technical support to African manufacturers of antimalarial drugs that would help bring their products up to WHO-approved standards – thus ensuring wider use of locally-produced drugs on the continent and beyond. The move […] Continue reading -> WHO Director General: Hopes COVID Global Health Emergency Can Be Declared Over in 2023 14/12/2022 Elaine Ruth Fletcher There are emerging hopes that sometime in 2023, WHO can declare that the COVID-19 global health emergency is over, said WHO Director General Dr Tedros Adhanom Ghebreyesus, speaking at a pre-holiday press briefing on Wednesday. Meanwhile, however, the world continues to invest some $2 trillion in wars and “killing each other” – but not nearly […] Continue reading -> Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Director General: Hopes COVID Global Health Emergency Can Be Declared Over in 2023 14/12/2022 Elaine Ruth Fletcher There are emerging hopes that sometime in 2023, WHO can declare that the COVID-19 global health emergency is over, said WHO Director General Dr Tedros Adhanom Ghebreyesus, speaking at a pre-holiday press briefing on Wednesday. Meanwhile, however, the world continues to invest some $2 trillion in wars and “killing each other” – but not nearly […] Continue reading -> Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Posts navigation Older postsNewer posts